Levocetirizin Saft Ucb Pharma

Levocetirizine dihydrochloride, the active ingredient in Levocetirizin Saft Ucb Pharma, is a selective peripheral H1‑receptor antagonist presented as an oral solution (syrup) for oral administration. It is indicated for the relief of symptoms of allergic rhinitis and for the management of chronic idiopathic urticaria in children and adults.

GNH USA supplies Levocetirizin Saft Ucb Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution channels that meet EU regulatory standards, and ensuring product integrity throughout the supply chain.

Levocetirizin Saft Ucb Pharma, a selective H1‑antihistamine, is used to manage allergic conditions mediated by histamine release.

Allergic rhinitis: reduces nasal congestion, sneezing, itching and watery eyes. Chronic idiopathic urticaria: alleviates wheal formation and itching associated with chronic hives. Allergic conjunctivitis: relieves eye itching, redness and tearing caused by histamine release.

Levocetirizin Saft Ucb Pharma may cause adverse reactions, which are generally mild to moderate in frequency.

Common Side Effects: - Drowsiness: mild sedation, especially after the first dose. - Headache: transient mild headache. - Dry mouth: sensation of oral dryness. - Fatigue: feeling of tiredness.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiac arrhythmia: rare cases of QT‑interval prolongation.

When prescribing Levocetirizin Saft Ucb Pharma, consider the following precautions to ensure safe use. - Renal impairment: dose adjustment may be required in patients with reduced kidney function. - Elderly patients: monitor for increased sedation. - Concomitant CNS depressants: avoid additive drowsiness. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Drug interactions: review patient’s medication list for potential interactions. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Levocetirizin may interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Ketoconazole: strong CYP3A4 inhibition can increase levocetirizine plasma levels. - Erythromycin: may raise levocetirizine concentrations. - Theophylline: additive CNS stimulation may occur.

Moderate Interactions (Monitor Closely): - Alcohol: can enhance drowsiness. - CNS depressants (e.g., benzodiazepines): may increase sedation. - Anticholinergic agents: may worsen dry mouth.